Biodefense Market Revenue Predicted To Go Up by 2020 - 2027
Biodefense Market Analysis, Size, Growth, Share,
Outlook & Forecast to 2027
The global biodefense market size is expected to reach USD 19.9 billion by 2027, expanding
at a CAGR of 5.9%, according to a new report by Grand View Research, Inc. Biodefense can
be briefly defined as comprehensive measures (identification, planning, and preparedness)
taken to rehabilitate the biosecurity of a country concerning biological threats or infectious
diseases that can be easily used as a bioweapon to instigate social destruction and bioterrorism.
Biological threats can be naturally occurring, accidental, or deliberate in origin. Factors like
the presence of favorable government initiatives, increasing investment by private players, and
the growing prevalence of various viral agents are fueling the market growth.
Previous incidents of bioterrorism caused by viral agents like anthrax, smallpox, botulism
have made biodefense a major focus area for advancements by countries to prevent
bioterrorism. In 2017, the Centre for Disease Control and Prevention (CDC) stated that they
had tracked more than 170 unique diseases globally and also identified outbreaks in more than
190 countries. In addition, according to the WHO, around 6, 50,000 people die of respiratory
diseases associated with seasonal flu annually. Repeated outbreaks of the Zika and Ebola virus
have coerced state governments to construct and strategize biodefense programs that will
assist in planning and responding during future outbreaks. In 2018, the U.S government
announced and issued the National Biodefense Strategy to manage the risk of biological
incidents by detecting and containing biothreats at its source, promoting biomedical
innovation, and improving emergency response. These factors are expected to boost market
growth over the forecast period.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/wearable-
Biodefense Market Report Highlights
The anthrax segment dominated the market in 2019. These bioagents possess a high risk of the
threat, can last long in the environment, and can be released easily into the environment
Others product segment which includes Zika, Ebola and Marburg’s virus is expected to reciprocate
highest CAGR over the forecast period due to rising outbreaks of diseases
North America dominated the market in 2019 owing to the presence of high federal funding,
technological advancements, and growing awareness among the population
Asia Pacific is expected to reciprocate the highest CAGR over the forecast period owing to growing
investment in R&D activities and the increasing threat of biowarfare.
Biodefense Market Segmentation
Grand View Research has segmented the global biodefense market on the basis of product and
Biodefense Product Outlook (Revenue, USD Million, 2016 - 2027)
Biodefense Regional Outlook (Revenue, USD Million, 2016 - 2027)
o The U.S.
o The U.K.
Middle East & Africa
o South Africa
Get Sample Copy of Report @ https://www.grandviewresearch.com/industry-
List of Key Players of Biodefense Market
Emergent Biosolutions Inc.
Dynavax Technologies Corporation
Elusys Therapeutics Inc.
Ichor Medical Systems
Dynport Vaccine Company
Alnylam Pharmaceuticals Inc.
Table of Content
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10.1 Objective - 1:
1.10.2 Objective - 2:
1.10.3 Objective - 3:
1.10.4 Objective - 4:
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Biodefense Market: Variables, Trends, & Scope
3.1 Market Segmentation And Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
For More Information: http://www.grandviewresearch.com